VERTEX PHARMACEUTICALS INC

Ticker: VRTX CUSIP: 92532F100 Class: EQTY

Vantage Consulting Group Inc's Holding History (CIK: 0001843547)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 488 Value ($000) $229 Avg Close $434.05 Range $391.01 - $486.43
Q1 2024
Shares 576 Value ($000) $241 Avg Close $422.74 Range $403.43 - $448.40
Q4 2023
Shares 666 Value ($000) $271 Avg Close $369.42 Range $341.85 - $413.00
Q3 2023
Shares 678 Value ($000) $236 Avg Close $349.73 Range $335.82 - $367.00
Q2 2023
Shares 690 Value ($000) $243 Avg Close $336.94 Range $313.47 - $354.94
Q1 2023
Shares 835 Value ($000) $263 Avg Close $299.93 Range $282.21 - $325.19
Q4 2022
Shares 772 Value ($000) $223 Avg Close $304.77 Range $283.58 - $324.75
Q3 2022
Shares 875 Value ($000) $253 Avg Close $287.72 Range $271.61 - $305.95
Q2 2022
Shares 945 Value ($000) $266 Avg Close $267.66 Range $233.01 - $293.17
Q1 2022
Shares 972 Value ($000) $254 Avg Close $237.33 Range $214.66 - $263.58
Q4 2021
Shares 1,252 Value ($000) $275 Avg Close $194.45 Range $176.36 - $224.49
Q3 2021
Shares 1,292 Value ($000) $234 Avg Close $195.24 Range $180.02 - $204.88
Q2 2021
Shares 1,177 Value ($000) $237 Avg Close $209.17 Range $185.33 - $222.78
Q4 2020
Shares 322 Value ($000) $76 Avg Close $229.44 Range $202.57 - $280.99